Stay updated with breaking news from Nasdaq Atra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $28.00 price target on shares of Atara Biotherapeutics in a research note on Tuesday, […]
HC Wainwright restated their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a $28.00 target price on the biotechnology company’s stock. Separately, StockNews.com began coverage on shares of Atara Biotherapeutics in a report on Thursday, August […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) EVP Amar Murugan sold 8,672 shares of the company’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $1.65, for a total transaction of $14,308.80. Following the sale, the executive vice president now directly owns 265,391 shares of the […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) CFO Eric J. Hyllengren sold 8,186 shares of Atara Biotherapeutics stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $1.65, for a total value of $13,506.90. Following the completion of the sale, the chief financial officer now owns 217,956 […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 11,700,000 shares, a decrease of 11.4% from the June 15th total of 13,200,000 shares. Based on an average daily volume of 1,940,000 shares, […]